- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Segue Resources: Drilling Approved at Gascoyne Lithium Project
Segue Resources Limited (Segue or the Company) (ASX:SEG) is pleased to announce that all approvals have been received to undertake a maiden drilling programme at the Reid Well lithium-caesium-tantalum (LCT) Prospect at the 100% owned Gascoyne Lithium Project in Western Australia. As quoted in the press release: The Company will complete a 2,500m RC drill …
Segue Resources Limited (Segue or the Company) (ASX:SEG) is pleased to announce that all approvals have been received to undertake a maiden drilling programme at the Reid Well lithium-caesium-tantalum (LCT) Prospect at the 100% owned Gascoyne Lithium Project in Western Australia.
As quoted in the press release:
The Company will complete a 2,500m RC drill programme to test the lateral extent, depth and orientation of the 1.8km x 1.2km, high grade Reid Well LCT prospect. Drilling is planned to commence in August 2017 and will take 3‐4 weeks to complete. Assay results are expected to be received by the end of September 2017.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.